A major advance in cancer investigation is occurring with the use of mini-antibodies to reactivate damaged p53. This crucial malignant inhibitor protein is frequently disabled in various kinds of tumors, causing https://sites2000.com/story11813427/nanobodies-reactivate-p53-the-new-hope-for-tumor-therapy